Bright Intangible Assets from 2010 to 2024

DRUG Stock  USD 1.10  0.04  3.77%   
Bright Minds' Intangible Assets are increasing over the last several years with slightly volatile swings. Intangible Assets are estimated to finish at about 2.4 B this year. Intangible Assets is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. View All Fundamentals
 
Intangible Assets  
First Reported
2010-12-31
Previous Quarter
2.3 B
Current Value
2.4 B
Quarterly Volatility
1.1 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bright Minds financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bright main balance sheet or income statement drivers, such as Depreciation And Amortization of 87.5 K, Interest Expense of 21.6 K or Selling General Administrative of 1.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.35. Bright financial statements analysis is a perfect complement when working with Bright Minds Valuation or Volatility modules.
  
This module can also supplement various Bright Minds Technical models . Check out the analysis of Bright Minds Correlation against competitors.

Latest Bright Minds' Intangible Assets Growth Pattern

Below is the plot of the Intangible Assets of Bright Minds Biosciences over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Bright Minds' Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bright Minds' overall financial position and show how it may be relating to other accounts over time.
Intangible Assets10 Years Trend
Slightly volatile
   Intangible Assets   
       Timeline  

Bright Intangible Assets Regression Statistics

Arithmetic Mean714,333,335
Geometric Mean2,044
Coefficient Of Variation147.15
Mean Deviation952,444,444
Median2.00
Standard Deviation1,051,126,719
Sample Variance1104867.4T
Range2.4B
R-Value0.83
Mean Square Error367704.1T
R-Squared0.69
Significance0.0001
Slope195,375,000
Total Sum of Squares15468143.3T

Bright Intangible Assets History

20242.4 B
20232.3 B
2020B

About Bright Minds Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Bright Minds income statement, its balance sheet, and the statement of cash flows. Bright Minds investors use historical funamental indicators, such as Bright Minds's Intangible Assets, to determine how well the company is positioned to perform in the future. Although Bright Minds investors may use each financial statement separately, they are all related. The changes in Bright Minds's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bright Minds's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Bright Minds Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Bright Minds. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Intangible Assets2.3 B2.4 B

Currently Active Assets on Macroaxis

When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Check out the analysis of Bright Minds Correlation against competitors.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for Bright Stock analysis

When running Bright Minds' price analysis, check to measure Bright Minds' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bright Minds is operating at the current time. Most of Bright Minds' value examination focuses on studying past and present price action to predict the probability of Bright Minds' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bright Minds' price. Additionally, you may evaluate how the addition of Bright Minds to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Is Bright Minds' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.30)
Return On Assets
(0.38)
Return On Equity
(0.72)
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.